We are live on ! Find out more
SMC

S. Muoio & Co Portfolio holdings

AUM $75.7M
1-Year Est. Return 42.51%
This Fund
S&P 500
This Quarter Est. Return
+16.77%
1 Year Est. Return
+42.51%
3 Year Est. Return
+327.42%
5 Year Est. Return
+691.71%
10 Year Est. Return
–
AUM
$111M
AUM Growth
+$15.9M
Cap. Flow
+$9.02M
Cap. Flow %
8.11%
Top 10 Hldgs %
47.05%
Holding
91
New
16
Increased
10
Reduced
12
Closed
20

Top Buys

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$3.56M
2
AGN
Allergan plc
AGN
+$2.16M
3
BOLD
Audentes Therapeutics, Inc
BOLD
+$2.14M
4
WBC
WABCO HOLDINGS INC.
WBC
+$2.02M
5
GBL
GAMCO Investors, Inc.
GBL
+$1.41M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$7.92M
2
CBM
Cambrex Corporation
CBM
+$2.99M
3
VIAB
Viacom Inc. Class B
VIAB
+$2.84M
4
GWR
Genesee & Wyoming Inc.
GWR
+$2.23M
5
MCRN
Milacron Holdings Corp.
MCRN
+$1.27M

Sector Composition

Rank Sector Weight
1 Communication Services 25.94%
2 Consumer Discretionary 12.54%
3 Healthcare 11.49%
4 Technology 9.42%
5 Financials 4.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIT
26
DELISTED
Fitbit, Inc. Class A common stock
FIT
$1.33M 1.2%
203,000
-97,000
-32% -$569K
SBGI icon
27
Sinclair Inc
SBGI
$997M
$1.29M 1.16%
38,600
+23,866
+162% +$889K
AAPL icon
28
Apple
AAPL
$4.9T
$1.22M 1.1%
16,648
– –
ENFC
29
DELISTED
Entegra Financial Corp.
ENFC
$1.19M 1.07%
39,407
– –
WAIR
30
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
$1.15M 1.04%
104,736
+35,047
+50% +$385K
MLNX
31
DELISTED
Mellanox Technologies, Ltd.
MLNX
$1.1M 0.99%
9,400
– –
LUMN icon
32
Lumen
LUMN
$6.47B
$1.09M 0.98%
82,850
– –
NTIP icon
33
Network-1 Technologies
NTIP
$34.1M
$1.05M 0.95%
483,708
+700
+0.1% +$1.54K
INXN
34
DELISTED
Interxion Holding N.V.
INXN
$1.04M 0.93%
12,376
-1,000
-7% -$83.5K
ARQL
35
DELISTED
Arqule Inc
ARQL
$998K 0.9%
+50,000
New +$580K
TR icon
36
Tootsie Roll Industries
TR
$2.94B
$982K 0.88%
35,364
– –
CBPX
37
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$911K 0.82%
+25,000
New +$822K
GOGO icon
38
Gogo Inc
GOGO
$484M
$902K 0.81%
140,949
– –
ACIA
39
DELISTED
Acacia Communications Inc
ACIA
$882K 0.79%
13,000
+8,000
+160% +$530K
ACHN
40
DELISTED
Achillion Pharmaceuticals
ACHN
$844K 0.76%
+139,907
New +$810K
GTX icon
41
Garrett Motion
GTX
$5.95B
$837K 0.75%
83,800
– –
PAHC icon
42
Phibro Animal Health
PAHC
$1.35B
$818K 0.74%
32,936
-44,100
-57% -$1.02M
KEM
43
DELISTED
KEMET Corporation
KEM
$812K 0.73%
+30,000
New +$729K
TIF
44
DELISTED
Tiffany & Co.
TIF
$802K 0.72%
+6,000
New +$709K
CARS icon
45
Cars.com
CARS
$670M
$702K 0.63%
57,466
-49,200
-46% -$574K
BRK.A icon
46
Berkshire Hathaway Class A
BRK.A
$1.06T
$679K 0.61%
2
– –
TRCB
47
DELISTED
Two River Bancorp
TRCB
$672K 0.6%
30,000
– –
DIS icon
48
Walt Disney
DIS
$170B
$648K 0.58%
4,480
– –
SMG icon
49
ScottsMiracle-Gro
SMG
$4.13B
$584K 0.53%
5,500
– –
TOO
50
DELISTED
Teekay Offshore Partners L.P.
TOO
$575K 0.52%
+373,217
New +$574K
1
2
3 4

Similar funds

FFMBT
First Farmers & Merchants Bank Trust Columbia, Tennessee $75.4M AUM 6.56% 1-Year Est. Return
NVPX
Norwest Venture Partners XII Palo Alto, California $75.4M AUM 53.35% 1-Year Est. Return
WM
Westpark Management Plano, Texas $75.3M AUM 22.07% 1-Year Est. Return
RA
Ratos AB Stockholm, Sweden $76.4M AUM
RC
Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return
GI
Gavea Investimentos Rj, Brazil $77.6M AUM 64.56% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
PIMH
Prudence Investment Management (HK) 12 Harcourt Road Central, Hong Kong $78.2M AUM 52.44% 1-Year Est. Return

S. Muoio & Co's Q4 2019 Portfolio in Review

As of Q4 2019, S. Muoio & Co held 91 positions worth $111M, up 17% from $95.3M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

S. Muoio & Co deployed $9.02M of net new capital in Q4 2019, opening 16 new positions and adding to 10 existing holdings. Its largest new stake was Audentes Therapeutics, Inc: 57,000 shares worth $3.41M.

By sector, the portfolio is most concentrated in Communication Services at 26% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Phibro Animal Health, an estimated $1.02M trimmed.

  • S. Muoio & Co's largest Q4 2019 buy was Audentes Therapeutics, Inc: 57,000 shares worth $3.41M.
  • S. Muoio & Co added most to Paramount Global Class B in Q4 2019, an estimated $3.56M increase.
  • S. Muoio & Co's biggest Q4 2019 reduction was Phibro Animal Health, cutting an estimated $1.02M.
  • S. Muoio & Co fully exited Celgene Corp in Q4 2019, selling an estimated $7.92M.
  • S. Muoio & Co's ten largest holdings make up 47% of its $111M portfolio in Q4 2019.
  • S. Muoio & Co opened 16 new positions and closed 20 in Q4 2019.
  • S. Muoio & Co's portfolio value rose 17% quarter-over-quarter to $111M.

Based on S. Muoio & Co's 13F filing for Q4 2019, filed 12 Feb 2020.